Xenon Pharmaceuticals (NASDAQ: XENE)
Xenon Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Xenon Pharmaceuticals Company Info
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
News & Analysis
3 Growth Stocks Near 52-Week Highs to Buy Anyway
These top performers have what it takes to keep providing outsized gains for patient investors.
Is Xenon Pharmaceuticals a Good Stock to Buy Now?
Despite the big run-up yesterday, there could be enough fuel to push this biotech stock even higher.
Why Xenon Pharmaceuticals Stock Is Screaming Higher Today
A positive mid-stage trial is powering this biotech stock higher today.
Is Now a Good Time To Buy Neurocrine Biosciences?
The biopharmaceutical company has seen shares rise 44.5% in less than two months.
3 High-Risk, High-Reward Stocks That Have Massive Upside Potential
If you can handle the uncertainty, these small-cap stocks can make you very wealthy.
3 Canadian Biotechs to Consider Buying Today
These developers of drugs for cancer, neurological conditions, and rare diseases may boost risk-taking investors' portfolios.
Valuation
Earnings Transcripts
Xenon Pharmaceuticals Inc (XENE) Q3 2020 Earnings Call Transcript
XENE earnings call for the period ending September 30, 2020.
Xenon Pharmaceuticals Inc (XENE) Q2 2020 Earnings Call Transcript
XENE earnings call for the period ending June 30, 2020.
Xenon Pharmaceuticals Inc (XENE) Q1 2020 Earnings Call Transcript
XENE earnings call for the period ending March 31, 2020.
Xenon Pharmaceuticals Inc (XENE) Q4 2019 Earnings Call Transcript
XENE earnings call for the period ending December 31, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.